+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North America Adenosine Triphosphate Swab Test Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type and Application

  • PDF Icon

    Report

  • 100 Pages
  • April 2021
  • Region: North America
  • The Insight Partners
  • ID: 5316737
UP TO OFF until Mar 31st 2024
The North America Adenosine Triphosphate (ATP) swab test market is expected to reach US$ 132.91 million by 2027 from US$ 69.83 million in 2019. The market is estimated to grow at a CAGR of 8.4% from 2020 to 2027. The growth of the market is attributed to the key driving factors such as rising prevalence of healthcare associated infections (HAI) and increasing emphasis on food safety. However, the limitations of ATP swab tests hinder the market growth.

The ATP Swab test is a fast calculation by identification of adenosine triphosphate or ATP of aggressively developing microorganisms. ATP is a molecule in and near living cells that explicitly tests the organisms' biological production and well-being. Healthcare-associated infectious (HAI) are caused while receiving treatments or therapies in healthcare facilities. These infections are related to surgical procedures and medical instruments used during operations. The rising prevalence of HAIs is one of the prominent factors driving the demand for ATP swab tests. For instance, according to a study published by the Centers for Disease Control and Prevention (CDC) in 2019, an estimated 1 in 31 hospital patients has some healthcare-associated infection (HAI) across the globe. Such a substantial prevalence of healthcare-associated disorders propels the adoption of the ATP swab test. Also, the utilization of adenosine triphosphate is a major indicator of cleanliness and sterilization in food & beverages. Hence, the rising incidence of foodborne diseases and food contamination is prominently expected to drive the growth of the North America Adenosine Triphosphate (ATP) swab test market during the forecast period.

The COVID-19 outbreak pandemic is adversely affecting countries in North America. In the US, all sanitization processes at hospitals, medical establishments, and high touch point surfaces in public places utilize Adenosine Triphosphate (ATP) Swab Test to confirm the surface is free from microorganisms, which boosts the growth of the North America Adenosine Triphosphate (ATP) swab test market. However, the growing number of COVID-19 confirmed cases has resulted in disruption in the supply chain due to a long period of lockdown, which hampers the market growth.

The North America Adenosine Triphosphate (ATP) Swab Test market, based on type, is segmented into free ATP test and microbial ATP test. In 2019, the microbial ATP test segment held a larger market share, and the market for the same segment is expected to grow at a faster rate during the coming years.

The North America Adenosine Triphosphate (ATP) Swab Test market, based on the application, is segmented into pharmaceutical & biotechnology company, food & beverage, hospitals & diagnostics laboratories, and academic & research institutions. In 2019, the pharmaceutical & biotechnology company segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest rate during the coming years.

A few of the primary and secondary sources referred to while preparing the report on the North America Adenosine Triphosphate (ATP) swab test market are the American Society of Testing and Material (ASTM), Centers for Disease Control and Prevention (CDC), and World Health organization (WHO).

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Adenosine Triphosphate (ATP) Swab Test Market - By Type
1.3.2 North America Adenosine Triphosphate (ATP) Swab Test Market - By Application
1.3.3 North America Adenosine Triphosphate (ATP) Swab Test Market - By Country
2. Adenosine Triphosphate (ATP) Swab Test Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Adenosine Triphosphate (ATP) Swab Test Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Expert Opinion
5. Adenosine Triphosphate (ATP) Swab Test Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Healthcare-Associated Infections (HAI)
5.1.2 Increasing Emphasis on Food Safety
5.2 Market Restraint
5.2.1 Limitations of ATP Swab Tests
5.3 Market Opportunity
5.3.1 Growing Spending on Patient Safety and Care
5.4 Future Trend
5.4.1 Development of Adenylate (A3) Concentration Based Modern Sterility Monitoring System
5.5 Impact Analysis
6. Adenosine Triphosphate (ATP) Swab Test Market - North America Analysis
6.1 North America Adenosine Triphosphate (ATP) Swab Test Market Revenue Forecast and Analysis
7. Adenosine Triphosphate (ATP) Swab Test Market Analysis and Forecasts To 2027 -Type
7.1 Overview
7.2 North America Adenosine Triphosphate (ATP) Swab Test Market Share by Type 2019 & 2027 (%)
7.3 Free ATP Test
7.3.1 Overview
7.3.2 Free ATP Test Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Microbial ATP Test
7.4.1 Overview
7.4.1.1 Microbial ATP Test: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
8. Adenosine Triphosphate (ATP) Swab Test Market Analysis and Forecasts To 2027 - Application
8.1 Overview
8.2 North America Adenosine Triphosphate (ATP) Swab Test Market Share by Application 2019 & 2027 (%)
8.3 Pharmaceutical and Biotechnology Company
8.3.1 Overview
8.3.1.1 Pharmaceutical and biopharmaceutical companies: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
8.3.2 Food and Beverage
8.3.2.1 Overview
8.3.2.2 Food and Beverage: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
8.3.3 Hospitals and Diagnostics Laboratories
8.3.3.1 Overview
8.3.3.2 Hospitals and Diagnostics Laboratories: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
8.3.4 Academic and Research Institutions
8.3.4.1 Overview
8.3.4.2 Academic and Research Institutions: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
9. Adenosine Triphosphate (ATP) Swab Test Analysis and Forecasts To 2027 - North America Analysis
9.1 North America: Adenosine Triphosphate (ATP) Swab Test Market
9.1.1 Overview
9.1.2 North America: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
9.1.3 US: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.3.1 US: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.3.2 US: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.3.3 US: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.4 Canada: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.4.1 Canada: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.4.2 Canada: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.1.4.3 Canada: Adenosine Triphosphate (ATP) Swab Test Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.5 Mexico: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.5.1 Mexico: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.5.2 Mexico: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.5.3 Mexico: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
10. Impact Of COVID-19 Pandemic on North America Adenosine Triphosphate (ATP) Swab Test Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Adenosine Triphosphate (ATP) Swab Test Market -Industry Landscape
11.1 Overview
11.2 Recent Growth Strategies in The Adenosine Triphosphate (ATP) Swab Test Market
12. Company Profiles
12.1 3M
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Hygiena, LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Charm Sciences
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Neogen Corporation
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ecolab
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Ruhof Healthcare Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 LuminUltra Technologies Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 MERCK KGaA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the Publishers
13.2 Glossary of Terms, Adenosine Triphosphate (ATP) Swab Test Market

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M
  • Hygiena, LLC
  • Charm Sciences
  • Neogen Corporation
  • Ecolab
  • MERCK KGaA
  • Ruhof Healthcare Corporation
  • LuminUltra Technologies Ltd.

Table Information